Plasmodium Vivax Clinical Trials

8 recruitingLast updated: May 11, 2026

There are 8 actively recruiting plasmodium vivax clinical trials across 8 countries. Studies span Not Applicable, Phase 4, Phase 3. Top locations include Bangkok, Thailand, Antananarivo, Madagascar, Bình Phước, Vietnam. Updated daily from ClinicalTrials.gov.


Plasmodium Vivax Trials at a Glance

8 actively recruiting trials for plasmodium vivax are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Bangkok, Antananarivo, and Bình Phước. Lead sponsors running plasmodium vivax studies include University of Oxford, London School of Hygiene and Tropical Medicine, and Shoklo Malaria Research Unit.

Browse plasmodium vivax trials by phase

Treatments under study

About Plasmodium Vivax Clinical Trials

Looking for clinical trials for Plasmodium Vivax? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Plasmodium Vivax trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Plasmodium Vivax clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Clinical Study to Assess Minimum Mosquito Bites for P. Vivax Infection in Thai Adults

Plasmodium vivax infection
University of Oxford24 enrolled1 locationNCT07257965
Recruiting
Phase 3

Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar

Malaria,FalciparumMalaria, VivaxPlasmodium Vivax+1 more
London School of Hygiene and Tropical Medicine19,200 enrolled2 locationsNCT06923592
Recruiting
Not Applicable

Vivax Malaria Human Infection Studies in Thailand

Plasmodium vivax infection
University of Oxford6 enrolled1 locationNCT04083508
Recruiting
Not Applicable

A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes

Plasmodium vivax infection
University of Oxford48 enrolled1 locationNCT05071079
Recruiting
Phase 3

FocaL Mass Drug Administration for Vivax Malaria Elimination

Plasmodium Vivax MalariaMalaria
University of California, San Francisco7,530 enrolled1 locationNCT05690841
Recruiting
Phase 4

ACT vs CQ With Tafenoquine for P. Vivax Mono-infection

Plasmodium Vivax MalariaMalariaMalaria, Vivax
Shoklo Malaria Research Unit606 enrolled1 locationNCT05788094
Recruiting
Phase 4

Southeast Asia Dose Optimization of Tafenoquine

Plasmodium Vivax Malaria
University of Oxford700 enrolled5 locationsNCT04704999
Recruiting
Phase 4

Efficacy and safety of pyronaridine-artesunate for the treatment of uncomplicated Plasmodium falciparum malaria and chloroquine for the treatment of uncomplicated Plasmodium vivax malaria in Binh Phuoc, Gia Lai and Phu Yen provinces, Viet Nam in 2021.

Patients infected Plasmodium vivaxPatients infected Plasmodium falciparum
World Health Organization42 enrolled3 locationsACTRN12621001743853